Alcon Elevates Vitreoretinal and Cataract Surgery for Superior Efficiency* with UNITY VCS and UNITY CS
The new, versatile platform offers two configurations, a combined console (VCS) as well as a standalone cataract system (CS). This platform is designed to deliver superior efficiency for vitreoretinal and cataract surgery, while enabling exceptional outcomes for patients.
Intensity Therapeutics, Inc. Announces $2.35 Million Public Offering
The Series B-1 warrants will have an exercise price of $0.85 per share, will be immediately exercisable and will expire 5 years from issuance. The Series B-2 warrants will have an exercise price of $0.85 per share, will be immediately exercisable and will expire 18 months from issuance.
Carr Tech Corp Celebrates FDA 510(k) Class II Approval of FROG All-in-One Filter Needle
This transformative device advances safety and efficiency in drug preparation, underscoring the startup’s journey from solo founder to FDA-cleared innovator.
Veracyte Announces Expanded Availability of Decipher Prostate Test to Patients with Metastatic Prostate Cancer
The Decipher Prostate test, already widely used for patients with localized disease, is now the only gene expression test available and covered by Medicare to inform treatment decisions for patients across the full continuum of prostate cancer risk.
The Gut-Brain Axis: How Your Microbiome Could Be Shaping Your Mental Health

Lately, people have started to look at mental health in a much wider way, not just focusing on brain chemicals and medicines. Medication is still a big part of treatment for lots of people, but it’s becoming clear that other things also matter. Things like sleep, inflammation, and yes — the gut — are all […]
Second Phase of ADVANTAGE AF study of FARAPULSE ™ Pulsed Field Ablation System Meets Primary Safety and Efficacy Endpoints
Trial achieves positive results in the treatment of persistent atrial fibrillation.
Interim HealthCare Names 2025 Nurse of the Year
Legare Boyle, RN, of Greenville, South Carolina rewarded for compassionate patient care and heroic community service during Hurricane Helene recovery .
Overture Life Secures $57M in Total Funding | Earns U.S. CLIA License to Deliver Reliable, Scalable IVF Automation
Overwater Ventures, GV, and Khosla Ventures invest in a rigorous clinical approach that raises throughput for fertility clinics, expands access, and empowers women to plan on their own terms.
CorWave Completes 6-Month In Vivo Study for Clinical Trials Initiation
In vivo studies demonstrated the pump’s successful operation for a period of up to six months. Additionally, nine chronic ovine implants were conducted for 60 days with no device failure or sign of thrombosis at explant. These significant milestones mark the final stage of CorWave’s preclinical development, paving the way for its First-In-Human study.
Vektor Medical Announces Post-Market Study Evaluating Benefit of AI-Powered Analysis to Identify and Ablate Non-Pulmonary Vein AF Targets
vMap is the only FDA-cleared non-invasive AI-powered arrhythmia analysis technology designed to improve, enhance, and accelerate ablation procedures, utilizing data from a standard 12-lead ECG.
Announcing RED® 72 SILVER LABEL | Now Featuring Penumbra’s Latest Engineering Enhancements Designed for Seamless Navigation

The new RED 72 SILVER LABEL with SENDit® Technology has shown a remarkable 50% increase in trackability over the original RED 72 with SENDit Technology.
Global Trauma Devices Market Report by iData Research | Uncovers $1.5B Growth Opportunity Driven by Titanium Implants, Modular Systems, and Surgical Robotics
A new 2025 Global Trauma Devices Market Report reveals critical insights for orthopedic device executives, product strategists, and investors seeking to navigate pricing pressures, material innovations, and shifting surgical practices in the orthopedic trauma sector.